Taysha Gene Therapies
TSHA
#5355
Rank
โ‚ฌ1.18 B
Marketcap
4,34ย โ‚ฌ
Share price
-0.20%
Change (1 day)
84.79%
Change (1 year)

Revenue for Taysha Gene Therapies (TSHA)

Revenue in 2025 (TTM): โ‚ฌ5.75 Million

According to Taysha Gene Therapies's latest financial reports the company's current revenue (TTM ) is โ‚ฌ5.41 Million. In 2024 the company made a revenue of โ‚ฌ8 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ13.97 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Taysha Gene Therapies from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ5.75 M-28.12%
2024 โ‚ฌ8 M-42.71%
2023 โ‚ฌ13.97 M499.23%
2022 โ‚ฌ2.33 M
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA